Core Insights - The China International Import Expo (CIIE) has become a significant platform for accelerating the availability of innovative drugs to Chinese patients, as highlighted by Novartis and Gilead Sciences [1][2] Group 1: Novartis - Novartis has showcased its innovative cardiovascular and renal treatment solutions at the CIIE, marking its eighth consecutive year of participation [1] - Several innovative drugs in the cardiovascular and renal fields have transitioned from exhibition to approval, benefiting from the spillover effects of the CIIE [1] Group 2: Gilead Sciences - Gilead Sciences has introduced two products at the CIIE, including the long-acting HIV prevention drug Lenacapavir and a new drug for primary biliary cholangitis, marking their Asian debut [1] - The company is actively advancing local R&D with 16 ongoing projects in China, including 10 in oncology and 6 in non-oncology, aiming for 90% of oncology projects to achieve global synchronization [2] - Gilead plans to sign nearly ten cooperation projects at the CIIE to enhance the accessibility of innovative drugs and promote standardized diagnosis and treatment [3]

Group 1 - In the first nine months of 2025, China established 48,921 new foreign-invested enterprises, marking a year-on-year increase of 16.2% [1][19][20] - Multinational companies are increasingly optimistic about the Chinese market, investing in production upgrades and establishing R&D centers despite changing international circumstances [1][22] - China's advantages, including a large market, complete supply chains, and innovation capabilities, continue to attract foreign investment [1][22] Group 2 - Bosch plans to invest 10 billion yuan in a smart driving control project in Suzhou, highlighting China's role as a key innovation base [2][4] - Roche Diagnostics announced a significant investment of 380 million Swiss francs in Suzhou for a new production and R&D base, marking its largest single investment in China [6][7] - Schneider Electric has established innovation centers in Beijing and Shanghai, emphasizing China's importance as a major market and innovation hub [8][9][11] Group 3 - Danfoss has made its 10th investment in China over the past 20 years, committing 2.7 billion yuan to create a future factory and zero-carbon industrial park in Jiaxing, Zhejiang [12][14][16] - The Chinese government's efforts to create a favorable environment for foreign investment are contributing to the country's attractiveness for multinational companies [22]

Core Insights - Greeco's 30th anniversary in China marks a significant milestone, showcasing its commitment to local sustainable development through smart manufacturing, local R&D, and green transformation [1][4][16] Manufacturing Network - Greeco established its first factory in Shanghai in 1995, initiating its "manufacturing in China" journey, and has since built a comprehensive manufacturing network centered in Shanghai, radiating nationwide [4] - The newly opened Fengxian factory serves as a model for Greeco's smart manufacturing upgrades, featuring AI visual inspection systems and AGV logistics robots to enhance quality control and operational efficiency [4][5] Digitalization and Efficiency - The factory is equipped with a digital dashboard and energy management systems for real-time monitoring of production metrics, ensuring product quality and safety throughout the manufacturing process [5] - This data-driven approach not only boosts production efficiency but also aligns with Greeco's commitment to delivering safe and reliable products to consumers [5] Local R&D and Product Innovation - Greeco's product innovation is deeply rooted in local insights, having established its first overseas R&D center in China in 1999, and was recognized as a foreign R&D center in 2023 [8] - Recent product developments include a 30% sugar reduction in the Baichun series to cater to Gen Z preferences, and the introduction of plant-based products that combine local flavors with health benefits [8][9] Revenue Growth and Market Strategy - Greeco's revenue from the Chinese market is projected to account for 45% of the group's overseas revenue in the fiscal year 2024, with a 60% year-on-year increase in operating profit [9] - The company has established 31 sales points across China, enhancing its localization strategy and utilizing multiple distribution channels to reach core cities and emerging markets [9] Green Manufacturing Initiatives - Greeco's factories are not only centers for smart manufacturing but also exemplify green transformation, with solar panels installed to generate approximately 458,000 kWh annually, reducing carbon emissions by about 192 tons [12] - The company has fully transitioned to using RSPO-certified sustainable palm oil in its products and has implemented FSC-certified packaging materials, contributing to environmental sustainability [12][13] Future Vision - Greeco aims to continue its mission of "Healthier Days, Wellbeing for Life," focusing on the integration of smart manufacturing, green factories, and health-conscious consumption to enhance consumer trust and product quality [16]